{
  "case_id": "Case_1_Cost_Test",
  "model_id": "google/gemini-2.5-flash",
  "content": "```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"Familial Mediterranean Fever (FMF)\",\n        \"confidence\": 0.9,\n        \"icd_code\": \"E85.0\",\n        \"reasoning\": \"Recurrent episodes of fever, severe abdominal pain with peritoneal signs, and arthritis, resolving spontaneously, in a patient of Somali descent (high prevalence in Mediterranean and Middle Eastern populations, including some East African groups) strongly suggest FMF. Family history of similar episodes further supports this.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Acute Intermittent Porphyria\",\n            \"confidence\": 0.6,\n            \"icd_code\": \"E80.21\",\n            \"reasoning\": \"Can cause acute, severe abdominal pain, often with neurological symptoms and tachycardia, and can be recurrent. However, arthritis and fever spikes are less typical as primary symptoms.\"\n        },\n        {\n            \"name\": \"Recurrent Appendicitis\",\n            \"confidence\": 0.4,\n            \"icd_code\": \"K35.80\",\n            \"reasoning\": \"Can present with recurrent abdominal pain and peritoneal signs, but typically localized to the right lower quadrant. Systemic symptoms like widespread arthritis and fever spikes to 39.5\u00b0C are less common, and spontaneous resolution without surgery is unusual for true appendicitis.\"\n        },\n        {\n            \"name\": \"Systemic Lupus Erythematosus (SLE) with serositis/arthritis flares\",\n            \"confidence\": 0.5,\n            \"icd_code\": \"M32.10\",\n            \"reasoning\": \"Can cause recurrent fevers, arthritis, and serositis (peritoneal inflammation). However, the acute, self-limiting nature of the episodes and the strong family history of similar episodes are less typical for SLE, which is usually more chronic and progressive.\"\n        },\n        {\n            \"name\": \"Inflammatory Bowel Disease (Crohn's Disease)\",\n            \"confidence\": 0.3,\n            \"icd_code\": \"K50.90\",\n            \"reasoning\": \"Can cause abdominal pain, fever, and arthritis (extraintestinal manifestations). However, the sudden onset and complete resolution of episodes, without chronic bowel symptoms or weight loss, make it less likely.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Recurrent episodes of severe abdominal pain with peritoneal signs\",\n        \"Fever spikes to 39.5\u00b0C\",\n        \"Arthritis affecting knees and ankles\",\n        \"Episodes last 2-3 days and resolve spontaneously\",\n        \"Recent immigrant from Somalia (ethnic background with higher prevalence of FMF)\",\n        \"Similar episodes in family members\",\n        \"Elevated CRP and ESR during episodes\",\n        \"Pain unresponsive to standard analgesics\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Genetic testing for MEFV gene mutations\",\n            \"purpose\": \"Confirm diagnosis of FMF. This is the gold standard for definitive diagnosis.\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Acute phase reactants (repeat CRP, ESR, SAA)\",\n            \"purpose\": \"Monitor inflammation during and between episodes; elevated SAA is characteristic of FMF.\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Complete Blood Count (CBC) with differential\",\n            \"purpose\": \"Assess for leukocytosis, anemia, and other systemic inflammatory markers.\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Urinalysis and urine culture\",\n            \"purpose\": \"Rule out urinary tract infection or renal involvement.\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"Abdominal Ultrasound/CT scan\",\n            \"purpose\": \"Rule out surgical causes of abdominal pain (e.g., appendicitis, cholecystitis, ovarian pathology); may show ascites or bowel wall thickening during flares in FMF but often non-specific.\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Serum amylase and lipase\",\n            \"purpose\": \"Rule out pancreatitis.\",\n            \"priority\": \"urgent\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Pain management with non-opioid options or judicious opioid use if severe (consider NSAIDs if not contraindicated, though often ineffective in FMF flares)\",\n            \"Antipyretics for fever\",\n            \"IV fluids for hydration if unable to tolerate oral intake\",\n            \"Consider short course of corticosteroids for acute severe flares if FMF is highly suspected and genetic testing is pending, or colchicine loading dose if tolerated.\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Colchicine\",\n                \"dose\": \"0.6 mg\",\n                \"route\": \"PO\",\n                \"duration\": \"Daily, lifelong\",\n                \"rationale\": \"First-line prophylactic treatment for FMF to prevent attacks and amyloidosis. Start once FMF is suspected and after ruling out acute surgical abdomen.\"\n            },\n            {\n                \"drug\": \"NSAIDs (e.g., Ibuprofen)\",\n                \"dose\": \"400-600 mg\",\n                \"route\": \"PO\",\n                \"duration\": \"As needed during flares\",\n                \"rationale\": \"For symptomatic relief of arthritis and pain during flares, though often not fully effective for severe pain.\"\n            },\n            {\n                \"drug\": \"Ondansetron\",\n                \"dose\": \"4 mg\",\n                \"route\": \"IV/PO\",\n                \"duration\": \"As needed\",\n                \"rationale\": \"For nausea and vomiting if present during flares.\"\n            }\n        ],\n        \"monitoring\": [\n            \"Vital signs (temperature, heart rate, blood pressure) every 4-6 hours during acute episode\",\n            \"Pain level assessment every 2-4 hours\",\n            \"Fluid intake and output\",\n            \"Inflammatory markers (CRP, ESR, SAA) during and between episodes to assess disease activity and treatment response\",\n            \"Renal function and urine for proteinuria (due to risk of amyloidosis) routinely once FMF diagnosis is established.\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"Expertise in diagnosis and long-term management of autoinflammatory diseases like FMF, including medication management and monitoring for complications.\"\n            },\n            {\n                \"specialty\": \"Genetics\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"For genetic counseling and interpretation of MEFV gene testing results.\"\n            },\n            {\n                \"specialty\": \"General Surgery\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"To evaluate for acute surgical abdomen given peritoneal signs, especially during initial presentation, until FMF diagnosis is probable.\"\n            },\n            {\n                \"specialty\": \"Social Work/Interpreter Services\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"To address language barrier, provide cultural context, and assist with healthcare access and patient navigation.\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Signs of acute surgical abdomen (e.g., rigid abdomen, persistent rebound tenderness, hemodynamic instability) despite recurrent nature of episodes.\",\n        \"Development of new neurological symptoms or significant weakness.\",\n        \"Signs of renal dysfunction or significant proteinuria (suggestive of amyloidosis, a severe complication of untreated FMF).\",\n        \"Persistent symptoms or failure to resolve spontaneously after 3 days.\",\n        \"Inability to tolerate oral medications or fluids.\"\n    ],\n    \"patient_education\": [\n        \"Explain the likely diagnosis (FMF) and its genetic basis, emphasizing it's a chronic condition but manageable with medication.\",\n        \"Importance of lifelong colchicine therapy to prevent attacks and serious complications like amyloidosis, and potential side effects.\",\n        \"How to recognize and manage disease flares, including when to seek medical attention.\",\n        \"Importance of regular follow-up with rheumatology.\",\n        \"Access to interpreter services for all medical appointments and understanding of medical information.\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Within 1 week with Rheumatology, sooner if symptoms worsen or new symptoms appear.\",\n        \"conditions\": \"Recurrence of severe pain or fever, development of new symptoms (e.g., rash, swelling, neurological changes), signs of dehydration, inability to take medications.\"\n    },\n    \"confidence_in_assessment\": 0.85,\n    \"uncertainties\": [\n        \"Exact MEFV gene mutation type (requires genetic testing).\",\n        \"Response to colchicine, as some patients may be resistant.\",\n        \"Presence of any underlying complications like amyloidosis (requires further workup, e.g., urinalysis for proteinuria, SAA levels).\"\n    ]\n}\n```",
  "latency": 10.209099054336548,
  "timestamp": "2025-08-10T10:45:23.701082",
  "cached_at": "2025-08-10T10:45:23.701093"
}